The Association of the British Pharmaceutical Industry
Medicines are transforming our lives like never before.
We want the UK to be the best place in the world to research, develop and use the medicines and vaccines of the future.
- VALUING AND ACCESSING MEDICINES
- RESEARCH, DEVELOPMENT AND MANUFACTURING
- WORKING IN PARTNERSHIP
- Industry Reputation
- International Policy, Trade & IP
- HEALTH DATA
VALUING AND ACCESSING MEDICINES
Value and Access
Medicines bring huge value to NHS patients. The development of new medicines is uncertain, costly, and involves significant rates of failure. The pharmaceutical industry spends $160 billion per year on research and development.The private sector produces nearly all the medicines and vaccines available to us. Companies need to make a profit – and a return – on global investment in order to maintain investment in the next generation of medicines.
RESEARCH, DEVELOPMENT AND MANUFACTURING
RESEARCH, DEVELOPMENT AND MANUFACTURING
We're helping to build a thriving environment for medicine discovery so the UK can be the best place in the world to research and develop new medicines and vaccines.
WORKING IN PARTNERSHIP
WORKING IN PARTNERSHIP
We have a long-standing positive relationship with the NHS, and a record of facilitate the same across various parties across the Life Sciences sector. We believe in focusing collaboration on where it can add the most value in making innovation as widely available to patients as possible.
Industry Reputation
INDUSTRY REPUTATION
Everywhere, every day someone relies on the results of our work to ensure their health and wellbeing. We are proud of this and are committed to working with a wide range of people - patients, doctors, nurses, regulators and governments - in order to deliver medicines in an ethically responsible way. Patients are at the heart of everything that we do.
International Policy, Trade & IP
INTERNATIONAL, TRADE AND IP
The ABPI is working to ensure that the UK has the best relationship with our international partners for patients, public health and the life sciences sector.
HEALTH DATA
Health data
We aim to harness the UK’s health data to support the efficient design, feasibility, recruitment and conduct of the full range of clinical trials. We are helping the UK make the most of health-related data for future research and development into new medicines.

Industry’s proposals for a new Voluntary Scheme for Pricing, Access and Growth (VPAG)
The Association of the British Pharmaceutical Industry (ABPI) has published the industry’s vision for a new agreement with the government which will deliver for patients, the NHS and the economy.
Read our proposal for the new Voluntary Scheme on branded medicinesABPI Conference 2023
The ABPI’s 2023 flagship annual conference took place on 27 April 2023 and focussed on Growing the UK as a Global Hub for Life Sciences. Visit our hub for a roundup of the day.
Find out what happened at ABPI Conference 2023
Latest news

UK’s grand ambition for life sciences hinges on delivery
The government has moved closer to realising its life sciences vision with an ambitious and broad-ranging set of proposals to improve the clinical trials environment, but delivery and addressing acute commercial challenges remain the key to success.

Susan Rienow becomes President of the ABPI
Susan Rienow is taking up her role as President of the Association of the British Pharmaceutical Industry.

ABPI response to DHSC antimicrobial resistance research funding
UK government announces £39 million funding for antimicrobial resistance (AMR) research through the Global AMR Innovation Fund (GAMRIF).

Jessamy Baird of Sanofi named as new ABPI Vice-President Elect
New ABPI Vice-President Elect - Jessamy Baird
Latest blogs and events

Three steps to boost patient access to clinical trials in the UK
Oliver Buckley-Mellor, ABPI Research Policy Manager, sets out the key actions needed to get clinical trials back to full strength.

What a new UK-Swiss trade deal would mean for life sciences
Blog post from Claire Machin, Executive Director, International Policy at the ABPI

Reflections from the Patient Advisory Council
Emily Reuben, CEO and co-founder of Duchenne UK and member of the ABPI’s Patient Advisory Council from September 2021 to March 2023, reflects on her time as part of the Council.

Online Workshop on SMC: How to prepare and submit to SMC | 12-13 June 2023
Making high quality, evidence-based submissions to SMC can mean the difference between successful or very limited access to NHS Scotland for medicines.
Key content hubs

The COP26 summit will bring parties together to accelerate action towards the goals of the Paris Agreement and the UN Framework Convention on Climate Change.

As a critical part of the health care community in the UK, the pharmaceutical industry wants to play the biggest possible role in the response to COVID-19.

The ABPI Code of Practice sets out the requirements the industry must comply with and supports companies’ commitment to self-regulation and to operate in a professional, ethical and transparent manner.
A date for your diary if visiting #NHSConfedExpo:
— ABPI (@ABPI_UK) June 6, 2023
⭐️15 June, 1.10pm, In Conversation zone
⭐️Discussion - Increasing diversity in clinical trials to reduce health inequalities
⭐️Featuring @ImogenShillito of @NIHRresearch and other distinguished guests.
Join us! pic.twitter.com/eVdmxzEq6Z
🚨Last chance to register for @OHENews live webinar on sustainability in the pharmaceutical industry🚨
— ABPI (@ABPI_UK) June 6, 2023
Get your ticket here: https://t.co/uJm8vDTi65#Sustainability https://t.co/DCnrlFSx3E
A date for your diary if visiting #NHSConfedExpo:
— ABPI (@ABPI_UK) June 6, 2023
⭐️14 June, 1.10pm, In Conversation zone
⭐️Discussion - the NHS at 75: learning from international successes to improve the UK health system
⭐️Featuring @SivaAnandaciva of @TheKingsFund and other distinguished guests.
Join us! pic.twitter.com/j7lTGX8zi7
Don't miss the opportunity to learn about BSI's new #Antimicrobialresistance Certification program🦠
— ABPI (@ABPI_UK) June 5, 2023
Register now for the launch event tomorrow and discover how you can help protect public health: https://t.co/132q8qOAuk#AMR @BSI_UK @AMRAlliance https://t.co/GC4F2FgIm3
The Pharmaceutical Industry in the UK
![Turnover [1]](/media/b10ppsss/40-8bn-turnover.jpg)
![R and D Investment [2]](/media/ouqnhlry/figures-r-d-investment-5-0bn.jpg)
![Gross Value Added (GVA) [4]](/media/fi4hkeqh/figures-gva-14bn.jpg)
Members
Online members portal (ABPI Meetings via Adam.ai)
ABPI members can log in for bespoke content and services.